This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Guanglan Zhang: Innovator in Peptide Identification and Tissue Typing
Introduction
Guanglan Zhang is a notable inventor based in Brighton, MA (US). He has made significant contributions to the fields of immunology and tissue typing through his innovative patents. With a total of 2 patents, Zhang's work has advanced the understanding of conserved peptide blocks and their applications in medical diagnostics.
Latest Patents
Zhang's latest patents include "Identification of conserved peptide blocks in homologous polypeptides" and "Oligonucleotide array for tissue typing." The first patent provides methods for identifying conserved peptide blocks in three or more homologous polypeptides. This invention is particularly useful for selecting conserved peptides in variable viral polypeptides for use in immunogenic compositions. The second patent focuses on oligonucleotide-based microarrays for tissue typing, specifically HLA tissue typing. These high-resolution arrays are valuable for diagnostic evaluations and determining donor/recipient transplant compatibility.
Career Highlights
Guanglan Zhang is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to contribute to groundbreaking research. His work has implications for improving transplant compatibility and enhancing immunogenic responses in patients.
Collaborations
Zhang has collaborated with esteemed colleagues such as Vladimir Brusic and Ellis L Reinherz, further enriching his research endeavors and expanding the impact of his inventions.
Conclusion
Guanglan Zhang's innovative work in peptide identification and tissue typing exemplifies the importance of research in advancing medical science. His contributions are paving the way for improved diagnostic and therapeutic strategies in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
